Center-Authored Papers

Filters: Author is Tsao, Anne S  [Clear All Filters]
2011
Tsao AS, Garland L, Redman MW, Kernstine K, Gandara D, Marom EM.  2011.  Reply to the Letter to the Editor Entitled A Practical Guide to Measure "All" Malignant Pleural Mesothelioma Tumors by Modified RECIST Criteria? Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 6(12):2144-5.
Garland LL, Chansky K, Wozniak AJ, Tsao AS, Gadgeel SM, Verschraegen CF, Dasilva MA, Redman MW, Gandara DR.  2011.  Phase II Study of Cediranib in Patients with Malignant Pleural Mesothelioma: SWOG S0509.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 6(11):1938-45. Abstract
2015
Ou S-HI, Moon J, Garland LL, Mack PC, Testa JR, Tsao AS, Wozniak AJ, Gandara DR.  2015.  SWOG S0722: phase II study of mTOR inhibitor everolimus (RAD001) in advanced malignant pleural mesothelioma (MPM).. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 10(2):387-91. Abstract
2016
Tsao AS, Scagliotti GV, Bunn PA, Carbone DP, Warren GW, Bai C, de Koning HJ, Yousaf-Khan UA, McWilliams A, Tsao MS et al..  2016.  Scientific Advances in Lung Cancer 2015.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. Abstract
2017